EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Comparison of Polynucleotide, Sodium Hyaluronate, and Crosslinked Sodium Hyaluronate for the Management of Painful Knee Osteoarthritis: A Multi-Center, Randomized, Double-Blind, Parallel-Group Study

Jee Youn Moon iD, Jeongsoo Kim, Jin Young Lee, Youngkwon Ko, Hue Jung Park, Young Hoon Jeon

Pain Medicine · 2023

DOI: 10.1093/pm/pnac155 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Pain Medicine, 2023. Verfasst von Jee Youn Moon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Hyaluronic Acid, Osteoarthritis, Knee. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Pharma Research, Gangneung, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare the clinical effectiveness of sodium polynucleotide, classic hyaluronic acid, and crosslinked hyaluronic acid for the management of painful knee osteoarthritis.

Design

Randomized, double-blind, parallel-group clinical trial.

Setting

Multicenter study. Subjects Patients with chronic painful knee osteoarthritis.

Methods

Ninety patients were selected and randomized into polynucleotide, classic hyaluronic acid, and crosslinked hyaluronic acid groups (30 per group). Intra-articular injections of the viscosupplement for each group were administered to the patients three times at one-week intervals. The primary outcome was differences in changes of weight-bearing pain scores at 16 weeks between the groups. The secondary outcomes were changes in the intensity of knee pain during weight-bearing, walking, and rest, and functional disability, quality of life, and adverse events during the 16-week follow-up period.

Results

At 16 weeks, the polynucleotide group showed a higher reduction in pain score using a Visual Analog Scale score (0–100) than the classic hyaluronic acid (−17.6 [95% CI = −35.1 to −0.1]; P = .048) and crosslinked hyaluronic acid (−22.4 [95% CI = −41.5 to −3.3]; P = .016) groups. The polynucleotide and crosslinked hyaluronic acid groups showed an early-onset reduction in knee pain during weight-bearing, walking, and rest. All three groups showed reductions in functional disability and improved quality of life at 16 weeks without inter-group differences. No severe adverse events were reported throughout the study period.

Conclusion

Polynucleotide significantly relieves pain more and relieves pain faster in patients with knee osteoarthritis than classic and crosslinked hyaluronic acid, with improved health-related quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronic AcidOsteoarthritis, KneeHumansQuality of LifeKnee JointPainTreatment OutcomeDouble-Blind MethodInjections, Intra-Articular

Stichwörter der Autor:innen

Crosslinked Sodium HyaluronateIntra-Articular InjectionKnee OsteoarthritisPolynucleotide SodiumSodium Hyaluronate

Substanzen

Hyaluronic Acid

Autor:innen und Institutionen

  • Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University, Seoul, Republic of Korea.
  • Department of Anesthesiology and Pain Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea.
  • Department of Anesthesiology and Pain Medicine, Seoul St. Mary's Hospital College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Anesthesiology and Pain Medicine, Kyugpook National University College of Medicine, Daegu, Republic of Korea.

ORCID-Profile: Jee Youn Moon

Förderung

  • Pharma Research, Gangneung, Republic of Korea

Zitieren

APA

Moon, J. Y., Kim, J., Lee, J. Y., Ko, Y., Park, H. J., & Jeon, Y. H. (2023). Comparison of Polynucleotide, Sodium Hyaluronate, and Crosslinked Sodium Hyaluronate for the Management of Painful Knee Osteoarthritis: A Multi-Center, Randomized, Double-Blind, Parallel-Group Study. Pain Medicine. https://doi.org/10.1093/pm/pnac155

Vancouver

Moon JY, Kim J, Lee JY, Ko Y, Park HJ, Jeon YH. Comparison of Polynucleotide, Sodium Hyaluronate, and Crosslinked Sodium Hyaluronate for the Management of Painful Knee Osteoarthritis: A Multi-Center, Randomized, Double-Blind, Parallel-Group Study. Pain Medicine. 2023. doi:10.1093/pm/pnac155

BibTeX
@article{Moon2023,
  author = {Moon, Jee Youn and Kim, Jeongsoo and Lee, Jin Young and Ko, Youngkwon and Park, Hue Jung and Jeon, Young Hoon},
  title = {Comparison of Polynucleotide, Sodium Hyaluronate, and Crosslinked Sodium Hyaluronate for the Management of Painful Knee Osteoarthritis: A Multi-Center, Randomized, Double-Blind, Parallel-Group Study},
  journal = {Pain Medicine},
  year = {2023},
  doi = {10.1093/pm/pnac155}
}
Kostenlos starten →